Sub menu

 

 

Kadmon Oceania Pty Ltd

Regulatory activities for this sponsor.

Type

Date

Filters applied:Clear all
1 result(s) found, displaying 1 to 1

  • Rholistiq

    Prescription medicine decision summary
    TGA decision: Rholistiq (belumosudil mesilate) is approved to treat chronic graft-versus-host disease (GVHD)